Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> Stronger US Sales Bolster Baxter’s 2Q Profit
FDAnews Device Daily Bulletin
July 23, 2012
| Vol. 9 No. 143
Stronger US Sales Bolster Baxter’s 2Q Profit
Baxter International said its net income rose 7 percent in the second quarter on one-time gains and better sales of a hemophilia drug, blood plasma products and dialysis devices.
Businessweek
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Briefs
Riverpoint Warning Cites CAPA, Documentation Shortcomings
Supplier Control Issues Cited in Warning to German Devicemaker
Supplier Reevaluation Failures Behind Electromedical Warning Letter